United States · Bill · HR
H.R. 2115 (116th)
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Introduced
8 April 2019
Last action
—
Status
Received in the Senate and Read twice and referred to the Committee on Finance.
Sponsors
—
Subjects
Discovery layer
Source updated
28 May 2025
Summary
Public Disclosure of Drug Discounts Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
8 official files
Referred in Senate (text)
Referred in Senate (text)
Referred in Senate · EN · 29 October 2019
Referred in Senate (PDF)
Referred in Senate · EN · 29 October 2019
Engrossed in House (text)
Engrossed in House · EN · 28 October 2019
Engrossed in House (PDF)
Engrossed in House · EN · 28 October 2019
Passed House
summary · EN · 28 October 2019
Introduced in House (text)
Introduced in House · EN · 8 April 2019
Introduced in House (PDF)
Introduced in House · EN · 8 April 2019
Introduced in House
summary · EN · 8 April 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/2115
- Open data entity: https://api.congress.gov/v3/bill/116/hr/2115